Doximity, Inc. (NASDAQ:DOCS – Get Free Report) has been given a consensus recommendation of “Reduce” by the nine research firms that are covering the company, Marketbeat Ratings reports. Three equities research analysts have rated the stock with a sell rating, four have assigned a hold rating and two have issued a buy rating on the company. The average 1 year price objective among analysts that have issued ratings on the stock in the last year is $36.30.
A number of equities analysts have commented on the stock. Wells Fargo & Company downgraded shares of Doximity from an “overweight” rating to an “equal weight” rating and decreased their price objective for the stock from $39.00 to $37.00 in a report on Monday, May 1st. Truist Financial decreased their price objective on shares of Doximity from $36.00 to $33.00 in a report on Monday, June 5th. Finally, Evercore ISI decreased their price objective on shares of Doximity from $33.00 to $32.00 in a report on Wednesday, May 17th.
Insider Buying and Selling
In other news, Director Timothy S. Cabral sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $35.00, for a total transaction of $262,500.00. Following the completion of the transaction, the director now directly owns 4,714 shares in the company, valued at $164,990. The sale was disclosed in a filing with the SEC, which can be accessed through this link. In other news, Director Timothy S. Cabral sold 7,500 shares of the company’s stock in a transaction that occurred on Wednesday, July 12th. The stock was sold at an average price of $35.00, for a total transaction of $262,500.00. Following the completion of the transaction, the director now directly owns 4,714 shares in the company, valued at $164,990. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Timothy S. Cabral sold 10,000 shares of the company’s stock in a transaction that occurred on Monday, July 3rd. The stock was sold at an average price of $33.80, for a total value of $338,000.00. Following the transaction, the director now owns 4,714 shares of the company’s stock, valued at $159,333.20. The disclosure for this sale can be found here. Corporate insiders own 39.40% of the company’s stock.
Institutional Inflows and Outflows
A number of large investors have recently modified their holdings of DOCS. Bank of New York Mellon Corp grew its position in Doximity by 60.6% in the first quarter. Bank of New York Mellon Corp now owns 172,855 shares of the company’s stock valued at $9,004,000 after acquiring an additional 65,196 shares during the period. US Bancorp DE grew its position in Doximity by 325.4% in the first quarter. US Bancorp DE now owns 2,646 shares of the company’s stock valued at $138,000 after acquiring an additional 2,024 shares during the period. Cambridge Investment Research Advisors Inc. grew its position in Doximity by 417.4% in the first quarter. Cambridge Investment Research Advisors Inc. now owns 21,099 shares of the company’s stock valued at $1,099,000 after acquiring an additional 17,021 shares during the period. Natixis Advisors L.P. bought a new stake in Doximity in the first quarter valued at $983,000. Finally, BlackRock Inc. grew its position in Doximity by 53.6% in the first quarter. BlackRock Inc. now owns 2,052,183 shares of the company’s stock valued at $106,898,000 after acquiring an additional 716,547 shares during the period. 52.17% of the stock is currently owned by institutional investors and hedge funds.
Doximity Trading Down 1.4 %
DOCS stock opened at $34.11 on Friday. Doximity has a twelve month low of $22.91 and a twelve month high of $47.46. The company has a market capitalization of $6.64 billion, a P/E ratio of 65.60, a PEG ratio of 11.86 and a beta of 0.92. The firm has a 50 day simple moving average of $32.79 and a 200-day simple moving average of $33.28.
Doximity (NASDAQ:DOCS – Get Free Report) last released its quarterly earnings results on Tuesday, May 16th. The company reported $0.15 earnings per share for the quarter, topping analysts’ consensus estimates of $0.13 by $0.02. Doximity had a net margin of 26.92% and a return on equity of 12.74%. The business had revenue of $110.97 million during the quarter, compared to the consensus estimate of $110.11 million. On average, research analysts predict that Doximity will post 0.66 EPS for the current year.
About Doximity
Doximity, Inc operates a cloud-based digital platform for medical professionals in the United States. The company’s platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.